(lp0
S"What are analysts saying about the future of Luminex Corporation's (LMNX ... Simply Wall St - 2 hours ago Luminex Corporation 's business is predicted to grow 76.5% during the next year. Are you considering investing?Luminex Corporation  Moves Higher on Volume Spike for March 17 - Equities.comLuminex Corporation  1-Year Price Target At $19.25 - Enterprise Leader"
p1
aS"Luminex Corporation Announces Initiation of Cash Dividend PR Newswire  - Feb 21, 2017 AUSTIN, Texas, Feb. 21, 2017 /PRNewswire/ -- Luminex Corporation   today announced that its board of directors has authorized the initiation of a quarterly cash dividend to its shareholders, the first in the company's history.Shares of Luminex Corporation  Sees Large Outflow of Money - Energy Index"
p2
aS'Luminex Corporation Receives FDA Clearance for ARIES GBS Assay PR Newswire  - Jan 4, 2017 AUSTIN, Texas, Jan. 4, 2017 /PRNewswire/ -- Luminex Corporation  today announced that it has received FDA clearance for the ARIES Group B Streptococcus  Assay for antepartum detection of GBS colonization in pregnant women.'
p3
aS'Luminex Corporation Reports Third Quarter 2016 Results; Raises Full Year Guidance PR Newswire  - Oct 31, 2016 Leveraging its leadership position in molecular testing, Luminex is expanding its product offerings and is now the only company able to provide low and high plex, targeted and syndromic molecular testing solutions to microbiology and molecular ...'
p4
aS'Luminex Corporation Reports Fourth Quarter And Full Year 2016 Results PR Newswire  - Feb 6, 2017 AUSTIN, Texas, Feb. 6, 2017 /PRNewswire/ -- Luminex Corporation  today announced financial results for the fourth quarter and full year 2016 ended December 31, 2016.Luminex Corporation  Stock Price Down 6.9% After Analyst Downgrade - Sports PerspectivesLuminex  Posts Loss in Q4, Revenues Miss Estimates - Yahoo Finance'
p5
aS'Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 ... PR Newswire  - Jan 9, 2017 AUSTIN, Texas, Jan. 9, 2017 /PRNewswire/ -- Luminex Corporation  today announced that it expects revenues in the fourth quarter of 2016 to be approximately $72 million and approximately $271 million for the year.'
p6
aS'Luminex: Breaking Down 20% Returns In Infectious Markets Seeking Alpha - Jan 23, 2017 Broadening its leadership in infectious disease assays and constantly pushing for innovation, Luminex is poised for fundamental growth through rising revenue generation and multiple expansion.'
p7
aS'ARIES System and Flu A/B &amp; RSV Assay Evaluated by Erasmus MC in New Publication PR Newswire  - Nov 17, 2016 AUSTIN, Texas, Nov. 17, 2016 /PRNewswire/ -- Luminex Corporation  today announced that the internationally renowned Department of Viroscience at Erasmus Medical Center in Rotterdam, The Netherlands, has evaluated the ARIES&nbsp;...'
p8
aS'Luminex Corporation Receives CE-IVD Mark for ARIES System and ARIES HSV 1&amp;2 Assay PR Newswire  - Mar 21, 2016 &quot;We are excited to have received a CE-IVD mark for the ARIES System and ARIES HSV 1&amp;2 Assay and look forward to rapidly launching this revolutionary system in Europe,&quot; said Thomas Pracht, Managing Director, EMEIA, Luminex Corporation.'
p9
aS'Luminex Corporation  By The Numbers: Valuation in Focus Business Review - Mar 17, 2017 The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC.'
p10
a.